An instrument for facilitating transseptal delivery of a cardiac therapeutic device is positionable in a left ventricle. The instrument includes an elongate shaft having a tubular lumen, the shaft having a proximal portion and a distal portion actively steerable between a generally straight position and a curved position. An external pull wire and an internal pull wire are each actuatable to move the distal portion to the curved position. The external pull wire extends internally through the proximal portion of the shaft and longitudinally along the exterior of the distal portion of the shaft, while the internal pull wire extends internally through the proximal portion of the shaft adjacent to the external pull wire, and extends internally through the distal portion of the shaft.
|
1. A redirector positionable in a left ventricle, the redirector comprising:
an elongate shaft having a tubular lumen, the shaft having a proximal portion and a distal portion actively steerable between a generally straight position and a curved position;
an external pull wire and an internal pull wire, the external and internal pull wires moveable in a proximal direction to move the distal portion along only a single bending plane to the curved position, wherein the external pull wire extends internally through the proximal portion of the shaft and has an exposed portion that extends longitudinally along the exterior of the distal portion of the shaft, wherein the internal pull wire extends internally through the proximal portion of the shaft directly adjacent and in parallel to the external pull wire, and extends internally through the distal portion of the shaft.
19. A redirector positionable in a left ventricle, the redirector comprising:
an elongate shaft having a tubular lumen, the shaft having a proximal portion and a distal portion actively steerable between a generally straight position and a curved position;
an internal pull wire and an external pull wire directly adjacent to the internal pull wire, wherein the external pull wire extends internally through the proximal portion of the shaft and longitudinally along the exterior of the distal portion of the shaft, wherein when the shaft is in the curved position, the external pull wire locks the shaft in the curved position;
a return wire extending longitudinally through the shaft, the return wire extending parallel to, and positioned 180 degrees from, the internal and external pull wires,
first and second actuators each moveable in a proximal direction and a distal direction, the first actuator operatively associated with the internal and external pull wires and the second actuator operatively associated with the return wire, the first and second actuators operatively coupled such that first and second actuators are moveable simultaneously in opposite ones of the proximal and distal directions.
2. The redirector of
3. The redirector of
4. The redirector of
5. The redirector of
6. The redirector of
7. The redirector of
8. The redirector of
9. The redirector of
10. The redirector of
11. The redirector of
12. The redirector of
13. The redirector of
14. The redirector of
15. The redirector of
16. The redirector of
17. The redirector of
18. The redirector of
20. The redirector of
21. The redirector of
22. The redirector of
23. The redirector of
|
This application claims the benefit of U.S. Provisional Application No. 62/802,212, filed Feb. 7, 2019, which is incorporated hereby reference.
Various medical procedures in use today involve passage of devices from the right side of the heart to the left side across the inter-atrial septum in a well-established technique known as transseptal catheterization.
Commonly owned application Ser. No. 16/578,375, entitled Systems and Methods for Transseptal Delivery of Percutaneous Ventricular Assist Devices and Other Non-Guidewire Based Transvascular Therapeutic Devices, filed Sep. 22, 2019, which is incorporated herein by reference, discloses a system and method for delivering therapeutic devices positionable at the aortic valve, and gives as a primary example pVADs. In that application, transseptal catheterization is used to deliver a long flexible cable such that it extends from the venous vasculature through the heart to the arterial vasculature. Once positioned the cable has one end extending from the right subclavian vein and an opposite end extending from the right or left femoral artery. A grasper is attached to the cable at the femoral artery, and the cable is withdrawn from the right subclavian vein to position the grasper along the route previously occupied by the cable. The grasper is then attached at the right subclavian vein to a pVAD and pulled from the femoral artery while the pVAD is simultaneously pushed at the right subclavian vein. This combination of pulling and pushing force moves the pVAD into the heart, across the septum and the mitral valves, and into its final position at the aortic valve.
Commonly owned co-pending application PCT/US2017/62913, filed Nov. 22, 2017 and Published as WO/2018/098210, which is incorporated herein by reference, discloses a system and method for delivering mitral valve therapeutic devices to the heart (such as devices for positioning a replacement mitral valve or devices for treating a native mitral valve) using a transseptal approach. In that application, transseptal catheterization is used to position a cable that helps to deliver a therapeutic device to the mitral valve site. Once it is positioned the cable has one end extending from the right femoral vein and an opposite end extending from the left or right femoral artery. The mitral valve therapeutic device is attached to the cable at the right femoral vein. The cable is then pulled at the femoral artery while the mitral valve therapeutic device is simultaneously pushed at the right femoral vein. This combination of pulling and pushing force moves the mitral valve therapeutic device into the heart, across the septum and to its final position at the mitral valve.
A common challenge of each of the above procedures is the need to prevent the cable or grasper from causing major leakage or damage to the mitral valve leaflets and the mitral valve chordae tendineae, especially when strong forces are being used to push and pull the potentially bulky therapeutic device (e.g. the pVAD or mitral valve therapeutic device) across the interatrial septum and downwardly into the mitral valve, there is a strong tendency to cause the loop of the cable running through the heart to be pulled upwardly into the valve structures. This application describes a left ventricle redirector “LVR” configured to retain the cable lower in the heart during this step, where it can safely avoid the mitral valve structures. The LVR also includes steering capability that can be used to aid in the steering of the therapeutic device through the mitral valve. This can help with final steering of a mitral valve therapeutic device into the center of the mitral valve ring at an angle that is perpendicular to the mitral valve ring plane. For procedures where the therapeutic device is to be positioned at or across the aortic valve (such as a pVAD or aortic valve therapeutic device) the steering allows movement of the pVAD safely through the center of the mitral valve with optimal final positioning across the aortic valve.
Another protective function served by the disclosed LVR is the isolation of the shaft of the cable or grasper from surrounding tissue at times when the cable/grasper is under load. In each of the above procedures, the step of pushing or pulling the cable or grasper is carried out with that device extending through the LVR, so that the walls of the LVR shaft prevent direct contact between the grasper/cable and the surrounding tissue and passages. This avoids disruption of the valve structures or damage to the cardiac apex when a pushing force or tension is applied to the grasper or cable.
An embodiment of a left ventricle redirector (LVR) is shown in
An outer jacket 118 of polymeric material (e.g. polyether block amide, “PEBA,” such as that sold under the brand name Pebax) covers the braid 112. During manufacture of the shaft, the polymeric material is positioned over the braid and subjected to a reflow process to flow the polymeric material over the braid. The material properties of the polymeric material vary along the length of the shaft. This is discussed below.
The distal end of the shaft is moveable between the generally straight position shown in
One of the pull wires 114a exits the sidewall of the shaft near the shaft's distal end, runs along the exterior of the shaft in a distal direction, and re-enters the shaft at the distal end of the shaft, while the other pull wire 114b does not exit the shaft at the distal end. The dual pull wire configuration advantageously allows articulation to the desired curvature and locking of the articulation in that curvature despite high loads experienced at the tip of the LVR during use.
The pull wire 114b that remains inside the shaft (“internal pull wire”) helps maintain the patency of the shaft's lumen during articulation, preventing the shaft from buckling or kinking despite the large degree of articulation as would likely happen if the construction used only the external pull wire.
The pull wire 114a that exits the shaft (the “external pull wire”) functions as a locking mechanism to lock the shaft in its articulated orientation, preventing the curve from opening when the outer circumference of the curve is against the left ventricular apex and forces are exerted against the distal tip of the LVR. During use of the LVR in the manner described in the discussion of
Another, related, feature of the LVR is that when its tip is subjected to the forces described in the prior paragraph, the length of the pull wire 114b that is exposed outside the shaft 102 remains generally constant.
Note that the terms “pull wire” and “wire” are not intended to mean that the pull wires must be formed of wire, as these terms are used more broadly in this application to represent any sort of tendon, cable, or other elongate element the tension on which may be adjusted to change the shape of the LVR. Also, while the term “straight” is used to refer to the shape of the LVR distal portion in its non-articulated position, it should be pointed out that the catheter's inherent flexibility in the non-articulated position may cause it to bend under forces of gravity when held upright, or to curve when tracked over a curved cable or wire, or advanced into contact with another structure. The term “straight” thus should not be used to interpret this application or the corresponding claims as requiring the distal portion of the shaft to hold a straight shape when in the non-articulated position.
The pull wire and return wire configuration shown in
The shape of the curve formed on actuation of the pull wires may differ for different embodiments. In the example shown in
The distance between the distal location at which the pull wire 114a re-enters the shaft and the distalmost end of the shaft tip may also vary between embodiments. In the
The cross-section view of
Material properties of the LVR components will next be described, although materials having different properties may be used without departing from the scope of the invention. The materials for the shaft are selected to give the LVR enough column strength to be pushed through the vasculature, torqued, and tracked over a cable or wire through the aortic arch, articulated at the distal tip section 122 without kinking, and to allow the outer circumference of the curve formed when it is articulated to be pressed into the left ventricle away from the mitral and aortic valves as will be described in connection with
Referring to
The next most distal section 126 uses a somewhat more flexible, but not highly flexible, material, such as 55D PEBA or similar material. Segment 126, during use, traverses the aortic arch and sits within the left ventricle.
Referring now to
In the distally adjacent segment 130, a slightly less rigid material is used (e.g. 55D PEBA). This is done to provide a gradual transition between the rigid segment 128 and the next adjacent segment 132 which is highly flexible. The transition segment helps to avoid buckling.
Segment 132 is the longest segment within the distal tip section 122 and it is designed to facilitate bending of the shaft into the curve during articulation using the pull wires. It has a jacket made from a very flexible material (e.g. 35D PEBA). The braid 112 (not shown in
Distally adjacent to flexible segment 132 is the segment 134 in which the pull wire 114a re-enters the shaft, and it is also the segment in which the pull wires 114a, 114b and return wire 116 are anchored to a pull ring (visible in dashed lines in
The distalmost segment 136 provides an atraumatic tip for the shaft. Also, during use of the LVR during medical procedures, another device is inserted into, pressed axially against, or received by, its distal tip as it is held securely in the left ventricle or disposed in the vasculature. The segment 136 must have sufficient wall thickness so that it will not collapse or tear when the other device (e.g. the RLC, discussed below in connection with
In one embodiment, the polymeric material of the distal segment 134 is doped with BaSO4 to allow the tip of the LVR to be seen on the fluoroscopic image. Alternatively, a marker band made from radiopaque material may be positioned near the tip.
The flexural properties, and thus the stiffness, of the LVR are sensitive to the durometer of the extrusions forming the shaft, the reinforcement configurations used in the shaft (e.g. the braid and reinforcing wire 117) and the geometry of the shaft. Table A below illustrates the gradient of polymer stiffness from region 132 of the shaft to region 126 for three different embodiments, the first being the first embodiment described above and having the cross-section shown in
TABLE A
Polymer Gradient
from Region 132
Embodiment
Region 132
Region 126
Region 124
to 126
1
35D
21
MPa
55D
170 MPa
72D-L25
510-1500
MPa
8
2
35D
21
MPa
55D
170 MPa
72D
510
MPa
8
3
80A
~4
MPa
72D
510 MPa
L25
1500
MPa
128
Embodiment 1 is provided with larger cross-sectional dimensions (wall thickness and diameter) than the other embodiments and can thus provide stiffness equivalent to that of Embodiment 2, without the need for the reinforcing wire 117. The region rigidity of the shaft increases by a factor of approximately two as it transitions from region 126 proximally to the region that is disposed within the handle.
Embodiment 2 depicted on the table above, includes the reinforcing wire 117 described in connection with
Embodiment 3 is provided with smaller cross-sectional dimensions, but it uses higher durometer polymers without a reinforcing wire 117. Compared with the other embodiments, it uses a lower durometer polymer in the articulation region 132 to ensure that the stiffness gradient through the length of the shaft localizes articulation to the region of the external pull wire 114a. This embodiment has a lower overall stiffness than the other two embodiments.
A discussion of the actuation mechanism for the pull wires 114a, 114b and return wire 116 will next be described. In general, the handle 104 is configured to move the pull wires 114a, 114b in a first direction (preferably proximally) while simultaneously moving the return wire 116 in a second, opposite direction (preferably distally), in order to articulate the LVR to the curved position. Reversing the respective directions of motion of the pull wires 114a, 114b and return wire 116 moves the LVR back to the generally straight position.
Referring to
The handle 104 includes a mechanism for simultaneously moving the sliders 150, 152 in opposite directions. Various mechanisms can be used for this purpose. One exemplary mechanism, shown in
The two pull wires 114a, 114b must travel different distances during articulation, due to the fact that the internal pull wire 114b traverses the curve resulting from the articulation from its position within the shaft, while the external pull wire 114a traverses a shorter path between the point at which it exits the shaft and the point at which it re-enters the shaft. The wires must therefore be actuated at different positions within the handle so as to ensure that the external pull wire 114a maintains equal or greater tension than the internal pull wire 114b. This avoids wire slack and ensures that the locking mechanism does not relax during application of forces F at the LVR's tip.
Distal to each actuation feature 115a, 115b is a corresponding feature of the slider that will engage that actuation feature as the slider 150 moves in the proximal direction (indicated by the arrow in
In an alternative arrangement shown in
In each of the above actuation embodiments, the distance by which external pull wire 114a will travel before internal pull wire 114b is engaged is selected to be the approximate difference between L1 and L2. In this calculation, L1 is the length of external pull wire 114a between its exit and entry points into and out of the shaft when the LVR is in the fully articulated position. L2 is the length traversed by the internal pull wire 114b along the internal circumference of the curve, measured between the points on the internal pull wire's path that are circumferentially adjacent to the points at which the adjacent external pull wire exits and then re-enters the shaft.
Method of Use
Use of the LVR in two different procedures will next be described with reference to
Before making use of the LVAD, transseptal catheterization is used to deliver a long flexible cable such that it extends from the venous vasculature through the heart to the arterial vasculature. Once positioned the cable has one end extending from the right subclavian vein (RSV) and an opposite end extending from the right femoral artery (RFA) or left femoral artery. Additional steps for positioning the cable are described in the co-pending application. After the cable is positioned the LVR may be tracked over the cable to the left ventricle LV. More specifically, the portion of the cable exteriorized at the RFA is backloaded through the LVR on the operating table. The LVR is advanced through the RFA sheath, advanced in the descending aorta and then further advanced around the aortic arch and into its destination in the left ventricle (LV).
The co-pending application describes devices that may be used to ensure that the edges around the open lumen of the LVR do not cause embolization of material from the roof of the aortic arch and to thereby avoid vascular damage or damage to the aortic valve. In one example described in that application a catheter (referred to as the “RLC”) extends over the cable from the venous side and extends trans-septally with its distal tip positioned in the descending aorta. After the LVR is advanced through the RFA sheath, it is advanced in the descending aorta until it contacts the tip of the RLC, and then both the RLC and the LVR are moved together, with the LVR being advanced as the RLC is being retracted at the same rate so as to keep the ends of the LVR and RLC in contact with one another. After this step the RLC is removed. In another example, the LVR has a dilator positioned at its distal end during its advancement over the cable, eliminating the need to have the RLC against the LVR during advancement of the LVR.
A grasper 143 comprising jaws or another grasping element 142 on a flexible shaft is attached to the part of the cable extending out the proximal end of the LVR at the femoral artery RFA. The other end of the cable is withdrawn from the RSV to draw the grasper along the route previously occupied by the cable, thus positioning the grasper with the grasping end external to the RSV and with the opposite end extending from the RFA. The distal tip section 122 of the LVR, which was previously positioned at the LV, is moved to its curved position by actuating the pull wires using the handle. As discussed above, this action locks the curve in the fully articulated position due to the action of the external pull wire 114a.
At the RSV, the grasping mechanism 142 (e.g. jaws) of the grasper is attached to a flexible pigtail-like member extending from the distal nose of a pVAD 140. The grasper is pulled from the femoral artery RFA while the pVAD is simultaneously pushed at the RSV. This combination of pulling and pushing force moves the pVAD into the heart, across the septum and the mitral valves, and into the LV. As the system advances towards the mitral valve, pushing on the LVR against the left ventricular apex as indicated by the arrow in
The grasping mechanism 142 and pig-tail like member of the pVAD enter the distal lumen of the LVR in the LV apex as depicted in
Before making use of the LVR, trans-septal catheterization is used to deliver a long flexible cable such that it extends from the venous vasculature through the heart to the arterial vasculature. Once positioned the cable has one end extending from the left or right femoral vein (RFV) and an opposite end extending from the right femoral artery (RFA) or left femoral artery (LFA—as shown).
A relatively rigid tubular device referred to as a segmental tensioner 146 is positioned over the cable, followed by the MVTD 144, with the distal tip of the MVTD being inserted into a proximal hub on the segmental tensioner. A cable lock locks the MVTD and segmental tensioner 146 assembly onto the cable.
The end of the cable that extends from the femoral artery is backloaded through the LVR on the operating table so that the LVR may be tracked over the cable to the LV. The LVR is advanced through the LFA sheath, advanced in the descending aorta and then further advanced around the aortic arch and into its destination in the left ventricle (LV). As discussed above, measures described in the co-pending application are taken to ensure that the edges around the open lumen of the LVR do not cause embolization of material from the roof of the aortic arch. These measures avoid vascular damage or damage to the aortic valve.
The distal tip section 122 of the LVR is moved to its curved position by actuating the pull wires using the handle, locking the curve in the fully articulated position due to the action of the external pull wire 114a.
The MVTD 144 is pushed from the venous side at the RFV to advance it toward the right atrium, led by the segmental tensioner 146, as the system is pulled by the cable from the LFA at the same rate in a coordinated manner. The segmental tensioner 144 leads the way as it crosses the interatrial septum and provides a gradual transition to the bigger and stiffer MVTD.
At this point, a significant pulling force is applied to the MVTD/tensioner assembly by the cable at the femoral artery. This force is slightly more than the “push” force on the MVTD 144 so as to pull the distal nose of the MVTD down and to the patient's left through the interatrial septum. Despite the pushing force of the LVR into the LV apex, with ever increasing pull force, there is a strong tendency to cause the loop of the cable contained in the steerable section of the LVR to be pulled upward into the mitral valve structures above. This tendency is overcome by the synergistic downward pushing force exerted by the segmental tensioner as it enters the lumen at the distal end of the LVR in the LV apex. It ensures that the cable that runs through the assembly is positioned away from the aortic and mitral valve leaflets and chordae tendineae by maintaining the cable safely away from the valve structures within the LVR's protective sleeve. Despite these forces, the LVR maintains its curved configuration as discussed above.
In addition to the importance of maintaining the cable LV apex, another key function of the LVR is to aid in the final steering of the MVTD into the center of the mitral valve ring at an angle that is perpendicular to the mitral valve ring plane. The user fine tunes the MVTD position within the ring through a combination of adjustments to pull wire tension, torqueing of the LVR, and push-pull of the LVR from the handle.
All patents and patent applications referred to herein, including for purposes of priority, are fully incorporated herein by reference.
Moran, Matthew, Johnson, Kevin, Stack, Richard S, Muldoon, Damian, Athas, William L, Feerick, Emer M, Ruddy, Liam
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
10105221, | Mar 07 2013 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiovascular prosthesis |
5190050, | Nov 08 1991 | Merit Medical Systems, Inc | Tip deflectable steerable catheter |
5285795, | Sep 12 1991 | Clarus Medical, LLC | Percutaneous discectomy system having a bendable discectomy probe and a steerable cannula |
5873842, | Aug 28 1991 | Medtronic, Inc. | Steerable stylet and manipulative handle assembly |
6004280, | Aug 05 1997 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Guiding sheath having three-dimensional distal end |
6183463, | Dec 01 1997 | Cordis Webster, Inc. | Bidirectional steerable cathether with bidirectional control handle |
6592581, | May 05 1998 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
6613046, | Nov 22 1999 | Boston Scientific Scimed, Inc | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
7056314, | May 30 2003 | Pacesetter, Inc | Steerable obturator |
7115134, | Jul 22 2002 | Chambers Technologies, LLC | Catheter with flexible tip and shape retention |
7481805, | Jun 27 2002 | Urotech GmbH | Drainage catheter |
7647124, | Nov 15 2005 | Medtronic, Inc. | Delivery catheter |
7729782, | Nov 15 2005 | Medtronic, Inc | Delivery catheter |
8096985, | May 07 2008 | ANCORA HEART, INC | Deflectable guide |
8235916, | Feb 03 2006 | Pacesetter, Inc. | System and method for manipulating insertion pathways for accessing target sites |
8435227, | Sep 28 2009 | Terumo Kabushiki Kaisha | Catheter for left coronary artery and engaging method therefor |
8606369, | Nov 15 2005 | Medtronic, Inc. | Delivery catheter |
8827982, | Feb 28 2007 | Medtronic, Inc | Pre-formed delivery catheters |
8926588, | Jul 05 2011 | Medtronic Vascular, Inc. | Steerable delivery catheter |
8996135, | Oct 23 2007 | Device and method for inserting a cardiac catheter | |
9072872, | Oct 29 2010 | Medtronic, Inc | Telescoping catheter delivery system for left heart endocardial device placement |
9078994, | Dec 17 2004 | BioCardia, Inc. | Method of accessing a contralateral femoral artery of a patient |
9173646, | Jan 20 2009 | ANCORA HEART, INC | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
9220874, | May 30 2012 | VASCULAR ACCESS TECHNOLOGIES, INC | Transvascular access device and method |
9320564, | May 05 2005 | Boston Scientific Scimed, Inc | Steerable catheter and method for performing medical procedure adjacent pulmonary vein ostia |
9511205, | Jul 05 2012 | PTMC INSTITUTE | Catheter-type therapeutic or diagnostic instrument provided with shaped wire members and catheter tube to be used together with shaped wire members |
9616197, | Jan 20 2009 | ANCORA HEART, INC | Anchor deployment devices and related methods |
9814814, | May 13 2014 | ABIOMED, INC | Cannula assembly |
20010005789, | |||
20030114832, | |||
20040003819, | |||
20040127847, | |||
20060089618, | |||
20060155158, | |||
20060167535, | |||
20060217794, | |||
20070032850, | |||
20070049906, | |||
20070060914, | |||
20070100299, | |||
20070112422, | |||
20070156233, | |||
20070299403, | |||
20100114306, | |||
20100160725, | |||
20100185172, | |||
20100198056, | |||
20100198192, | |||
20100198208, | |||
20100249491, | |||
20110022057, | |||
20120041422, | |||
20120101442, | |||
20120172656, | |||
20140107399, | |||
20140276395, | |||
20140276782, | |||
20140276904, | |||
20140303719, | |||
20140371719, | |||
20150258312, | |||
20150273136, | |||
20150305864, | |||
20150328382, | |||
20160022961, | |||
20160066993, | |||
20160074623, | |||
20160158506, | |||
20160213472, | |||
20160220785, | |||
20160317288, | |||
20160317289, | |||
20160367787, | |||
20170106170, | |||
20170224483, | |||
20170245988, | |||
20170258614, | |||
20170361065, | |||
20180043132, | |||
20180078370, | |||
20180104398, | |||
20180311421, | |||
20180318079, | |||
20190117937, | |||
20190151614, | |||
EP1534374, | |||
EP1807143, | |||
EP2687254, | |||
EP2913080, | |||
EP3142721, | |||
EP3288491, | |||
EP3302363, | |||
WO1994003227, | |||
WO200060995, | |||
WO2005037345, | |||
WO2006052651, | |||
WO2007149974, | |||
WO2008012914, | |||
WO2009137712, | |||
WO2010085456, | |||
WO2010085457, | |||
WO2012178115, | |||
WO2013181397, | |||
WO2014065714, | |||
WO2014138482, | |||
WO2014197962, | |||
WO2015175718, | |||
WO2016176409, | |||
WO2016196933, | |||
WO2017139246, | |||
WO2017155892, | |||
WO2018098210, | |||
WO2019055154, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Sep 22 2019 | Synecor LLC | (assignment on the face of the patent) | / | |||
Feb 16 2021 | FEERICK, EMER | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Feb 18 2021 | MORAN, MATTHEW | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Mar 02 2021 | MULDOON, DAMIAN | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Mar 29 2021 | STACK, RICHARD S | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Mar 29 2021 | ATHAS, WILLIAM L | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Mar 29 2021 | JOHNSON, KEVIN W | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 | |
Apr 08 2021 | RUDDY, LIAM | Synecor LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 059760 | /0013 |
Date | Maintenance Fee Events |
Sep 22 2019 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Oct 04 2019 | SMAL: Entity status set to Small. |
Date | Maintenance Schedule |
Jun 21 2025 | 4 years fee payment window open |
Dec 21 2025 | 6 months grace period start (w surcharge) |
Jun 21 2026 | patent expiry (for year 4) |
Jun 21 2028 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 21 2029 | 8 years fee payment window open |
Dec 21 2029 | 6 months grace period start (w surcharge) |
Jun 21 2030 | patent expiry (for year 8) |
Jun 21 2032 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 21 2033 | 12 years fee payment window open |
Dec 21 2033 | 6 months grace period start (w surcharge) |
Jun 21 2034 | patent expiry (for year 12) |
Jun 21 2036 | 2 years to revive unintentionally abandoned end. (for year 12) |